Infertility News and Research

RSS

Infertility primarily refers to the biological inability of a person to contribute to conception. Infertility may also refer to the state of a woman who is unable to carry a pregnancy to full term.

Columbia Laboratories to sell progesterone related assets and 11.2M shares to Watson Pharmaceuticals

Columbia Laboratories, Inc. has entered into a definitive agreement to sell substantially all of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc. for a $47 million upfront payment plus royalties of 10 to 20 percent of annual net sales of certain progesterone products. Additional payments up to $45.5 million can be earned by the successful completion of clinical development milestones in the ongoing PREGNANT Study, regulatory filings, receipt of regulatory approvals and product launches.

4 Mar 2010

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

For many women, unexplained hair loss can take a significant psychological toll on their overall quality of life. From altering their hairstyle to hide a thinning part to scaling back their hair care regimen in an effort to halt further hair loss, women try countless ways to cover up this problem - and the results are often lukewarm at best.

4 Mar 2010

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.

4 Mar 2010

Androxal Type C meeting: Repros Therapeutics receives FDA’s version of minutes

Repros Therapeutics Inc. today announced that the Company has received the FDA’s version of the minutes of the Type C meeting held on January 25, 2010. The minutes confirmed the Company’s interpretation of the points the Agency made during the meeting. In correspondence from the FDA prior to the meeting the Agency noted that they could not currently agree with the Company’s stated indication for the use of Androxal® in the treatment of secondary hypogonadism in men wishing to preserve fertility.

4 Mar 2010

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

The Canadian Fertility and Andrology Society supports fully the provision of publicly funded in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment across Canada. Infertility has been defined by the World Health Organization as a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.

3 Mar 2010

My Little Miracle Essay Contest: Winners to receive education fund prizes to support their children's future

If you are a parent who has conceived using Ferring Pharmaceuticals' fertility products, you can win a $10,000 education fund to support your child's future. Two other education fund prizes will also be awarded.

2 Mar 2010

Ferring Pharmaceuticals, GSN sign agreement to test Parental Support technology

Ferring Pharmaceuticals and Gene Security Network announced that they have signed an agreement to conduct a clinical trial of GSN's advanced preimplantation genetic diagnosis (PGD) technology, Parental Support™.

26 Feb 2010

Boston IVF The Maine Center opened to offer full range of infertility and reproductive health services

Boston IVF, a leading medical practice providing specialized infertility treatment since 1986, is expanding its patient care services in Maine and has opened Boston IVF The Maine Center, offering local patients state-of-the-art care closer to home.

25 Feb 2010

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

Women who become pregnant with a single foetus after in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) have an increased risk of a stillbirth, according to new research out today (Wednesday).

24 Feb 2010

Children born through assisted reproduction at greater risk of obesity and type 2 diabetes related defects

More than three million children have been born as a result of assisted reproductive technologies since the birth of the first "test tube baby" in 1978. While the majority of these children are healthy and normal, as a group they are at greater risk of certain kinds of birth defects and being low birth weight, which is associated with obesity, hypertension and type 2 diabetes later in life.

22 Feb 2010

UCSF team: NIH ethics guidelines for embryonic stem cell research need to be modified

A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.

19 Feb 2010

Infertility patients from across GTA demand government-funded IVF

Infertility patients from across the GTA gathered at Queen's Park this morning to demand government-funded in vitro fertilization (IVF). Larger than life children's building blocks on the steps of the provincial legislative building spelled out the $550 million the Ontario Expert Panel on Infertility and Adoption says the province could save in long term health care and social services costs by funding IVF.

16 Feb 2010

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.

12 Feb 2010

getSTDtested.com launches "Kiss Chlamydia Goodbye" campaign

getSTDtested.com, a physician driven, STD testing and treatment online clinic today announced a campaign called "Kiss Chlamydia Goodbye" to encourage young women to take action to prevent chlamydia.

12 Feb 2010

Vitrolife announces 14% increase in sales for fourth-quarter 2009

Sales increased by 14 percent during the fourth quarter and amounted to SEK 67 (59) million. Calculated in local currency growth was 15 percent. Sales for the year amounted to SEK 275 (225) million, corresponding to an increase of 22 percent. Calculated in local currencies growth was 10 percent.

10 Feb 2010

New Success Prime IVF Program launched

Reproductive Partners Medical Group, Inc. announces the launch of the Success Prime IVF Program, an IVF money back guarantee for best-case patients.

10 Feb 2010

New Multi-Cycle program reduces risk of infertility treatment for older mothers

Fertility experts at the Reproductive Science Center of the Bay Area (RSC) announced they have launched a new program from IntegraMed geared toward easing the risk of infertility treatment for qualified women of ages 49 and younger who want to use their own eggs in order to achieve pregnancy.

10 Feb 2010

Advanced paternal age increases autism risk only when the mother is younger

Advanced maternal age is linked to a significantly elevated risk of having a child with autism, regardless of the father's age, according to an exhaustive study of all births in California during the 1990s by UC Davis Health System researchers. Advanced paternal age is associated with elevated autism risk only when the father is older and the mother is under 30, the study found.

9 Feb 2010

Non-invasive MR Spectroscopy to determine ability to be fathers

Men with no sperm in their ejaculate—a condition known as azoospermia—may no longer need invasive procedures to determine if they have sperm in their testes according to a new study published in Human Reproduction.

5 Feb 2010

ARUP Laboratories adds three downstream cost calculators to its Suite of Utilization Management Services

ARUP Laboratories announced the release of three groundbreaking tools, downstream cost calculators, to its Suite of Utilization Management Services.

5 Feb 2010

Infertility News and Research

Further Reading

Columbia Laboratories to sell progesterone related assets and 11.2M shares to Watson Pharmaceuticals

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Androxal Type C meeting: Repros Therapeutics receives FDA’s version of minutes

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

My Little Miracle Essay Contest: Winners to receive education fund prizes to support their children's future

Ferring Pharmaceuticals, GSN sign agreement to test Parental Support technology

Boston IVF The Maine Center opened to offer full range of infertility and reproductive health services

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

Children born through assisted reproduction at greater risk of obesity and type 2 diabetes related defects

UCSF team: NIH ethics guidelines for embryonic stem cell research need to be modified

Infertility patients from across GTA demand government-funded IVF

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

getSTDtested.com launches "Kiss Chlamydia Goodbye" campaign

Vitrolife announces 14% increase in sales for fourth-quarter 2009

New Success Prime IVF Program launched

New Multi-Cycle program reduces risk of infertility treatment for older mothers

Advanced paternal age increases autism risk only when the mother is younger

Non-invasive MR Spectroscopy to determine ability to be fathers

ARUP Laboratories adds three downstream cost calculators to its Suite of Utilization Management Services

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News